Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?

To: Terp who wrote (117184)	1/27/2000 10:59:00 AM
From: SpinCity1	Respond to of 119973

TNTU looking good

To: Terp who wrote (117184)	1/27/2000 11:00:00 AM
From: MB6	Read Replies (1) \| Respond to of 119973

Keep an eye on RFGI. This one can explode at any moment. Has a small float and they will soon be a player in OLB's.

To: Terp who wrote (117184)	1/27/2000 11:01:00 AM
From: ekn	Read Replies (1) \| Respond to of 119973

IMDS first batch of news! 1/27/00 - IMAGING DIAGNOSTIC RELEASES LATEST IN-VIVO IMAGES OF CARCINOMA ON WEB SITE -------------------------------------------------------------------------------- FORT LAUDERDALE, Fla., Jan 27, 2000 /PRNewswire via COMTEX/ -- Imaging Diagnostic Systems Inc. (OTC Bulletin Board: IMDS) announced today that the Company has released its latest in-vivo clinical images. The images consist of breast cancers revealed by their CT Laser Mammography system. These images can be viewed on the Company's web site www.imds.com. The case studies released consist of different types of abnormalities within the breast. The first shows an Invasive Adenocarcinoma with Ductal and Lobular features. The second case shows a Ductal Carcinoma in Situ (DCIS) & Infiltrating Ductal Carcinoma (IDC). Histological examination of biopsy specimens confirmed the presence of cancer. "Both cases are significant because they demonstrate the CTLM(TM)'s ability to produce images based on the optical characteristics of abnormalities in the breast. The second case study is particularly significant because of the type of cancer that was revealed. The mammography in this case only depicted calcifications that formed due to cancer. The CTLM(TM), however, revealed a 1 cm mass that was not seen in the mammogram or felt during palpation," stated Richard Grable, CEO. Additional case studies will be released as they become available. Imaging Diagnostic Systems has developed the world's first patented laser-based breast mammography system that utilizes state-of-the-art laser technology and proprietary computed algorithms that create contiguous cross- sectional slice images of the breast without the use of breast compression. SOURCE Imaging Diagnostic Systems, Inc. (C) 2000 PR Newswire. All rights reserved. prnewswire.com -0- CONTACT: Deborah O'Brien of Imaging Diagnostic Systems, Inc., 954-581-9800 WEB PAGE: imds.com GEOGRAPHY: Florida INDUSTRY CODE: BIO MLM SUBJECT CODE: OTC (Voluntary Disclosure: Position- Long; ST Rating- Strong Buy; LT Rating- Strong Buy) Raging Bull Advertisement - myTrack online trading: Trade like a Pro. BoardMark MemberMark Ignore Poster Report TOS Violation IMDS Update Last 1.99 Chg. + 5/32 % +7.98% Time 10:40:00 Detailed \| Real-Time Nasdaq delayed 15 minutes, 20 min. otherwise.